BOSTON SCIENTIFIC CORPORATION Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value
BOSTON SCIENTIFIC CORPORATION (BSX) reported Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value of $31.00 million for the 12-month period ending 2014-12-31, per its 10-K filed 2017-02-23.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Consideration Transferred and Preacquisition Equity Interest in Acquiree
us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1 · last filed 2017-02-23
- BOSTON SCIENTIFIC CORPORATION business combination, step acquisition, equity interest in acquiree, fair value for the quarter ending 2014-12-31 was $0.00.
- BOSTON SCIENTIFIC CORPORATION business combination, step acquisition, equity interest in acquiree, fair value for fiscal 2014 was $31.00M.
| Period end | Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value 3 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value 9 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value 12 month |
|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $31.00M 10-K · filed 2017-02-23 | |
| 2014-09-30 | $31.00M 10-Q · filed 2015-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |